EA201591708A1 - Кристаллическая форма триэтиламиновой соли замещенной тиазолилуксусной кислоты - Google Patents
Кристаллическая форма триэтиламиновой соли замещенной тиазолилуксусной кислотыInfo
- Publication number
- EA201591708A1 EA201591708A1 EA201591708A EA201591708A EA201591708A1 EA 201591708 A1 EA201591708 A1 EA 201591708A1 EA 201591708 A EA201591708 A EA 201591708A EA 201591708 A EA201591708 A EA 201591708A EA 201591708 A1 EA201591708 A1 EA 201591708A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- crystal form
- triethylamine salt
- thiazolyoxic
- substituted
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
- C07D277/593—Z being doubly bound oxygen or doubly bound nitrogen, which nitrogen is part of a possibly substituted oximino radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Настоящее изобретение относится к кристаллической форме триэтиламиновой соли (2Z)-2-(2-амино-5-хлоротиазол-4-ил)-2-(3-N-трет-бутоксикарбониламинопропоксиимино)уксусной кислоты (формула I) Изобретение также относится к способам и промежуточным соединениям для получения указанной кристаллической формы. Кристаллическая форма пригодна как промежуточное соединение для получения антибиотиков гликопептид-цефалоспоринового ряда с поперечной межмолекулярной связью.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361779091P | 2013-03-13 | 2013-03-13 | |
PCT/US2014/021080 WO2014164187A1 (en) | 2013-03-13 | 2014-03-06 | Crystalline form of a substituted thiazolylacetic acid triethylamine salt |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201591708A1 true EA201591708A1 (ru) | 2016-01-29 |
EA027911B1 EA027911B1 (ru) | 2017-09-29 |
Family
ID=50382685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591708A EA027911B1 (ru) | 2013-03-13 | 2014-03-06 | Кристаллическая форма триэтиламиновой соли замещенной тиазолилуксусной кислоты |
Country Status (20)
Country | Link |
---|---|
US (1) | US9139542B2 (ru) |
EP (1) | EP2970164B1 (ru) |
JP (2) | JP6404309B2 (ru) |
KR (1) | KR20150126368A (ru) |
CN (1) | CN105121417B (ru) |
AU (1) | AU2014249611B2 (ru) |
BR (1) | BR112015022600A2 (ru) |
CA (1) | CA2902724A1 (ru) |
EA (1) | EA027911B1 (ru) |
ES (1) | ES2634019T3 (ru) |
GE (1) | GEP201706779B (ru) |
HK (1) | HK1214596A1 (ru) |
IL (1) | IL240600A0 (ru) |
MD (1) | MD4719C1 (ru) |
MX (1) | MX351963B (ru) |
PH (1) | PH12015502067A1 (ru) |
SG (1) | SG11201507221VA (ru) |
TW (1) | TWI627165B (ru) |
UA (1) | UA115087C2 (ru) |
WO (1) | WO2014164187A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112021023784A2 (pt) * | 2019-05-31 | 2022-01-04 | Hyundai Pharm Co Ltd | Forma cristalina i de um composto, método para preparar a forma cristalina i, e, composição farmacêutica para prevenir ou tratar uma doença metabólica |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4284631A (en) | 1978-07-31 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them |
US4372952A (en) | 1978-07-31 | 1983-02-08 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
US4341775A (en) | 1978-09-11 | 1982-07-27 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
GB2033377B (en) | 1978-09-11 | 1983-05-05 | Fujisawa Pharmaceuticalco Ltd | Cephem compounds and processes for preparation thereof |
US4220761A (en) | 1978-09-12 | 1980-09-02 | Fujisawa Pharmaceutical Co., Ltd. | 7-[Substituted oximinoacetamido]-3-[hydroxy alkyltetrazolo]cephalosporin derivatives |
DE2945248A1 (de) | 1978-11-13 | 1980-05-22 | Fujisawa Pharmaceutical Co | Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel |
EP0055465B1 (en) * | 1980-12-31 | 1989-08-23 | Fujisawa Pharmaceutical Co., Ltd. | 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof |
JP2519054B2 (ja) | 1986-06-09 | 1996-07-31 | 武田薬品工業株式会社 | 新規セフェム化合物 |
AU1630988A (en) | 1987-05-30 | 1988-12-01 | Kyoto Pharmaceutical Industries, Ltd. | Cephalosporin compound and pharmaceutical composition thereof |
JPH04221388A (ja) * | 1990-12-20 | 1992-08-11 | Asahi Chem Ind Co Ltd | セファロスポリン化合物およびその製造法 |
TWI335332B (en) | 2001-10-12 | 2011-01-01 | Theravance Inc | Cross-linked vancomycin-cephalosporin antibiotics |
ITMI20012363A1 (it) | 2001-11-09 | 2003-05-09 | Antibioticos Spa | Metodo per la sintesi di catene laterali di cefalosporine |
AU2003231833A1 (en) | 2002-05-24 | 2003-12-12 | Theravance, Inc. | Cross-linked glycopeptide-cephalosporin antibiotics |
GB0416379D0 (en) | 2004-07-22 | 2004-08-25 | Sandoz Ag | Organic compounds |
TW200637559A (en) | 2005-03-29 | 2006-11-01 | Shionogi & Co | 3-propenylcefem derivative |
-
2014
- 2014-03-06 CA CA2902724A patent/CA2902724A1/en not_active Abandoned
- 2014-03-06 JP JP2016500718A patent/JP6404309B2/ja active Active
- 2014-03-06 EP EP14712945.6A patent/EP2970164B1/en active Active
- 2014-03-06 TW TW103107729A patent/TWI627165B/zh not_active IP Right Cessation
- 2014-03-06 CN CN201480013807.7A patent/CN105121417B/zh active Active
- 2014-03-06 GE GEAP201413956A patent/GEP201706779B/en unknown
- 2014-03-06 MX MX2015012146A patent/MX351963B/es active IP Right Grant
- 2014-03-06 MD MDA20150099A patent/MD4719C1/ru active IP Right Grant
- 2014-03-06 US US14/198,975 patent/US9139542B2/en active Active
- 2014-03-06 UA UAA201509929A patent/UA115087C2/uk unknown
- 2014-03-06 SG SG11201507221VA patent/SG11201507221VA/en unknown
- 2014-03-06 BR BR112015022600A patent/BR112015022600A2/pt active Search and Examination
- 2014-03-06 KR KR1020157026105A patent/KR20150126368A/ko not_active Application Discontinuation
- 2014-03-06 AU AU2014249611A patent/AU2014249611B2/en not_active Ceased
- 2014-03-06 ES ES14712945.6T patent/ES2634019T3/es active Active
- 2014-03-06 WO PCT/US2014/021080 patent/WO2014164187A1/en active Application Filing
- 2014-03-06 EA EA201591708A patent/EA027911B1/ru unknown
-
2015
- 2015-08-17 IL IL240600A patent/IL240600A0/en unknown
- 2015-09-11 PH PH12015502067A patent/PH12015502067A1/en unknown
-
2016
- 2016-03-07 HK HK16102556.4A patent/HK1214596A1/zh not_active IP Right Cessation
-
2018
- 2018-08-15 JP JP2018152961A patent/JP2018197256A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2014249611B2 (en) | 2017-12-21 |
AU2014249611A1 (en) | 2015-09-17 |
HK1214596A1 (zh) | 2016-07-29 |
MD4719B1 (ru) | 2020-10-31 |
JP2018197256A (ja) | 2018-12-13 |
EP2970164B1 (en) | 2017-05-03 |
MD4719C1 (ru) | 2021-05-31 |
US9139542B2 (en) | 2015-09-22 |
PH12015502067B1 (en) | 2016-01-25 |
WO2014164187A1 (en) | 2014-10-09 |
IL240600A0 (en) | 2015-09-24 |
JP2016512257A (ja) | 2016-04-25 |
ES2634019T3 (es) | 2017-09-26 |
CN105121417B (zh) | 2017-11-17 |
BR112015022600A2 (pt) | 2017-07-18 |
GEP201706779B (en) | 2017-11-27 |
JP6404309B2 (ja) | 2018-10-10 |
TW201444810A (zh) | 2014-12-01 |
SG11201507221VA (en) | 2015-10-29 |
US20140275554A1 (en) | 2014-09-18 |
MD20150099A2 (ru) | 2016-02-29 |
UA115087C2 (uk) | 2017-09-11 |
CA2902724A1 (en) | 2014-10-09 |
KR20150126368A (ko) | 2015-11-11 |
PH12015502067A1 (en) | 2016-01-25 |
MX2015012146A (es) | 2015-11-25 |
EP2970164A1 (en) | 2016-01-20 |
TWI627165B (zh) | 2018-06-21 |
CN105121417A (zh) | 2015-12-02 |
MX351963B (es) | 2017-11-06 |
EA027911B1 (ru) | 2017-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
CR20140237A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
EA201890899A1 (ru) | Модуляторы фарнезоидного x-рецептора | |
EA201400735A1 (ru) | Производные альфа-амино бороновой кислоты, селективные ингибиторы иммунопротеасомы | |
CR20140238A (es) | Derivados nucleósidos con sustitución 2´, 4´- difluoro-2´-metilo como inhibidores de la replicación del arn del vhc | |
EA201690473A1 (ru) | Комбинированный состав двух противовирусных соединений | |
EA201890916A1 (ru) | Применение пидифлуметофена для снижения заражения растений микотоксинами | |
GT201400023A (es) | Derivados de 5-fluor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2 (1h) ona | |
EA201500875A1 (ru) | СОЛИ ПРОИЗВОДНЫХ 2-АМИНО-1-ГИДРОКСИЭТИЛ-8-ГИДРОКСИХИНОЛИН-2-(1Н)-ОНА, ОБЛАДАЮЩИЕ АГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К β2 АДРЕНЕРГИЧЕСКОМУ РЕЦЕПТОРУ И АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ ПО ОТНОШЕНИЮ К МУСКАРИНОВОМУ РЕЦЕПТОРУ М3 | |
EA201391489A1 (ru) | Композиции со сниженной вязкостью | |
EA201690844A1 (ru) | Ингибиторы gsk-3 | |
EA201992421A1 (ru) | Способ получения озанимода | |
EA201491820A1 (ru) | Новые тиенопиримидиновые производные, способы их получения и их терапевтические применения | |
EA201591567A1 (ru) | Новые производные пиридина | |
CY1118079T1 (el) | Μεθοδος παρασκευης του αλατος l-αργινινικης περινδοπριλης | |
EA201600248A1 (ru) | Антибактериальные производные 2h-индазола | |
MX359673B (es) | Preparacion de intermediarios de pirimidina utiles para la preparacion de maci tentano. | |
EA201591976A1 (ru) | Производные пурина в качестве агонистов каннабиноидного рецептора cb2 | |
EA201390292A1 (ru) | Ингибиторы деацетилазы на основе гидроксамата | |
EA201590116A1 (ru) | Способ получения замещенных триазолопиридинов | |
EA201591708A1 (ru) | Кристаллическая форма триэтиламиновой соли замещенной тиазолилуксусной кислоты | |
EA201790522A1 (ru) | Соль производного цефалоспорина, ее кристаллическое твердое вещество и способ ее получения | |
EA201270786A1 (ru) | α-КРИСТАЛЛИЧЕСКАЯ ФОРМА КАРБАБЕНЗПИРИДА | |
EA201591292A1 (ru) | Тапентадола малеат и его кристаллические формы | |
EA201490536A1 (ru) | Новая кристаллическая форма |